Why education must extend beyond patients to make a difference in diabetic eye disease
Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action
New research illuminates patient dissatisfaction despite successful restoration of vision following cataract surgery
Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision
Alcon launches Voyager direct selective laser trabeculoplasty device in the US
Voyager DSLT is already available in select markets in the EU and the UK, and reduces the specialised training required with manual selective laser trabeculoplasty
Postoperative considerations for retinal detachments following keratoprosthesis implantation
Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery
EMA validates indication extension application of pegcetacoplan for treatment of kidney disease
According to Apellis and Sobi, pegcetacoplan (Aspaveli) first received marketing authorisation for treatment of paroxysmal nocturnal hemoglobinuria
Hyperacute outer retinal dysfunction may be an underrecognised paediatric disorder
Children experienced sudden vision loss, visual field constriction, nyctalopia and dyschromatopsia following febrile illness
Heart Eye announces AI-driven retinal imaging system to detect biomarkers of cardiovascular health risks
The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March
Angiogenesis 2025: The global forecast for AI-driven home OCT
Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting
SpaMedica and Vision Express partner for UK training placement programme
The partnership with the NHS eye patient servicer will help preregistration optometrists access training in community and hospital settings
GenSight Biologics shares efficacy and safety findings from REFLECT Phase III gene therapy trial
The company shared 5-year results for lenadogene nolparvovec (Lumevoq), administered unilaterally and bilaterally to patients with Leber Hereditary Optic Neuropathy
Retinal biomarkers in OCT imaging may have predictive applications for nAMD
The authors evaluated shallow irregular pigment epithelial detachment, subretinal hyperreflective material, subretinal fluid, intraretinal fluid and other baseline OCT biomarkers
IOL design puts a new spin on vision
Advancements in lens technology reflect the growing popularity of multifocal lenses
Study shows high compliance with early-childhood vision screenings, pinpoints parental limitations
The study underscored a need for tailored approaches among specific patient populations
Veterinary ophthalmology can foster insights and progress in glaucoma care
Sarah M. Thomasy, DVM, PhD, DACVO, discusses the importance of examining how glaucoma affects companion animals like dogs, cats and horses
An accessible, free resource on genetic eye disease is changing patient education
Mariya Moosajee, MBBS, BSc, PhD, FRCOphth, discusses how Gene Vision is improving patients' lives on a global scale
Healthy lifestyles translate to lower risk of retinal disease
Researchers screened for outcomes such as the presence of retinal diseases including age-related macular degeneration and retinal vein occlusion
I. Paul Singh, MD, says artificial intelligence will help glaucoma specialists make decisions
The interventional glaucoma mindset can maximise quality of life, but requires clinicians to act fast
Study indicates age and gender are factors in ocular gene therapy outcomes
Researchers from the University of Bristol recorded increased instances of inflammation in particular demographic groups
EMA launches procedure for manufacturers working with high-risk medical devices
The European Medicines Agency's new standard procedure allows manufacturers to request advice from medical device expert panels
Helping patients with glaucoma manage mental health
The link between eye health and mental health may be deeper than previously believed
Ocular surface disease and other adverse effects linked to cosmetics, personal care products
The authors emphasised that consumers and clinicians should be made aware of potential ophthalmic adverse events associated with cosmetics and personal care products
Shifting the narrative around dry eye disease
A qualitative study method illuminates patients’ fears for the future
Italian study illuminates positive outcomes and common complications of SING IMT implantation
The implant was tested in eyes of patients with bilateral age-related macular degeneration who underwent cataract surgery
COVID-19 may impact anatomy of retina and functional vision
Choroidal and retinal changes were examined with optical coherence tomography angiography
Crafting an international database for retinopathy of prematurity
Intercontinental collaboration is key to unlocking ROP in our lifetime
A new home treatment for amblyopia
Binocular eye tracking could serve as alternative to patching and provide visual acuity gains with heightened adherence rates
US FDA approves continuous delivery ranibizumab treatment (Susvimo, Genentech) for diabetic macular oedema
Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States
Nuance Audio hearing aid glasses receive concurrent CE Mark and FDA approval
The hearing aid glasses from EssilorLuxottica received CE marking under the Medical Devices Regulation of the EMA
Ocugen, Inc. receives European Medicines Agency ATMP designation for new gene therapy
OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication
European Medicines Agency CHMP adopts positive opinions for two aflibercept biosimilars
Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration
